Although patients with AMLDNMT3A/FLT3/NPM1 tended to have shorter OS compared to those in the other mutation groups, the difference was not significant in the entire group as well as within the CN-AML group (p = 0.211 and p = 0.209, respectively). Here, FLT3 is linked to acute myeloid leukemia.